Suppr超能文献

建立并验证 UHPLC-ESI-MS/MS 法测定人尿液中选定的心血管药物、多酚及其代谢物

Development and validation of UHPLC-ESI-MS/MS method for the determination of selected cardiovascular drugs, polyphenols and their metabolites in human urine.

机构信息

Department of Analytical Chemistry, Silesian University of Technology, 7M. Strzody Str., 44-100 Gliwice, Poland.

出版信息

Talanta. 2012 Jan 30;89:47-56. doi: 10.1016/j.talanta.2011.11.055. Epub 2011 Nov 26.

Abstract

A sensitive ultra-performance liquid chromatography tandem mass spectrometry method with electrospray ionisation (UHPLC-ESI-MS/MS) was developed for the simultaneous determination of 52 compounds: β-blockers, polyphenols (antioxidants) and their metabolites in mixture of standards and after addition the 52 standard solutions to human urine samples. The analyses of urine samples obtained from patients treated with β-blockers were also carried out. The separation of analytes was performed on a Hypersil GOLD™ column (100 mm × 2.1mm, 1.9 μm) using a gradient elution profile for 10 min and mobile phase consisting of 0.1% formic acid in water and acetonitrile. In these conditions, some of the tested compounds were not separated, but this was compensated by the use of MS/MS detection. The drugs, polyphenols and their metabolites were detected with a tandem mass spectrometer after being ionised positively or negatively (depending on the molecule) using an electrospray ionisation (ESI) source. The MS system was operated in the selected reaction monitoring (SRM) mode, where one quantitation and one confirmation transition was done for each analyte. The quantitative method was validated for selectivity, linearity, low limits of quantitation, accuracy, precision, recovery, matrix effect and analyte stability. The LLOQ varied from 0.01 to 0.40 ng mL(-1) for β-blockers and from 0.05 to 40.0 ng mL(-1) for polyphenols. The linear range was 0.08-1000 ng mL(-1) for the drugs and 0.10-2300 ng mL(-1) for the polyphenols. Intra-day and inter-day precision was less than 8%, and the accuracy ranged from -4.40 to 2.23% for all analytes. The average recoveries for all compounds analysed were better than 90%. The developed method can be successfully used to monitor cardiovascular drugs and their metabolites in urine samples of patients treated with β-blockers and can also be used to study the effect of polyphenols on the metabolism of drugs.

摘要

建立了一种灵敏的超高效液相色谱-串联质谱法(UHPLC-ESI-MS/MS),用于同时测定 52 种化合物:混合物标准品中的β受体阻滞剂、多酚(抗氧化剂)及其代谢物,以及加入 52 种标准溶液后的人尿液样品。还对接受β受体阻滞剂治疗的患者的尿液样本进行了分析。在 10 分钟内,使用 Hypersil GOLD™柱(100mm×2.1mm,1.9μm)和水与乙腈中的 0.1%甲酸的梯度洗脱程序进行分析物分离。在这些条件下,一些测试化合物没有分离,但通过使用 MS/MS 检测进行了补偿。使用电喷雾电离(ESI)源将药物、多酚及其代谢物正离子化或负离子化(取决于分子)后,用串联质谱仪进行检测。MS 系统以选择反应监测(SRM)模式运行,对每个分析物进行一次定量和一次确证转换。定量方法进行了选择性、线性、低定量下限、准确度、精密度、回收率、基质效应和分析物稳定性验证。β受体阻滞剂的LLOQ 为 0.01-0.40ng/mL,多酚的 LLOQ 为 0.05-40.0ng/mL。药物的线性范围为 0.08-1000ng/mL,多酚的线性范围为 0.10-2300ng/mL。所有分析物的日内和日间精密度均小于 8%,准确度范围为-4.40%至 2.23%。所有化合物的平均回收率均大于 90%。所建立的方法可成功用于监测接受β受体阻滞剂治疗的患者尿液样品中的心血管药物及其代谢物,也可用于研究多酚对药物代谢的影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验